Exhibit 2b. This exhibit contains the loss share calculation for restructuring (loan mod), plus explanatory notes. Exhibit 2b CALCULATION OF RESTRUCTURING LOSS 1 Shared-Loss Month May-09 2 Loan no: 123456 Loan before Restructuring 3 Original loan amount 500,000 4 Current unpaid principal balance 450,000 5 Remaining term 298 6 Interest rate 7.500 % 7 Interest Paid-To-Date 2/29/08 8 Monthly payment - P&I 3,333 9 Monthly payment - T&I 1,000 10 Total monthly payment 4,333 11 Loan type (fixed-rate, ARM, I/O, Option ARM, etc.) Option ARM 12 Borrower current annual income 82,000 Terms of Modified/Restructured Loan 13 Closing date on modified/restructured loan 4/19/09 14 New Principal balance 461,438 15 Remaining term 313 16 Interest rate 3.500 % 17 Monthly payment - P&I 1,346 18 Monthly payment - T&I 800 19 Total monthly payment 2,146 20 Loan type (fixed-rate, ARM, I/O, Option ARM, etc.) IO Hybrid 00 Xxxx xxxx (0xx, 0xx) 0xx If adjustable: 22 Initial interest rate 3.500 % 23 Term - initial interest rate 60 Months 24 Initial payment amount 2,146 25 Term-initial payment amount 60 Months 26 Negative amortization? No 27 Rate reset frequency after first adjustment 6 Months 28 Next reset date 5/1/14 29 Index LIBOR 30 Margin 2.750 % 31 Cap per adjustment 2.000 % 32 Lifetime Cap 9.500 % 33 Floor 2.750 % 34 Front end DTI 31 % 35 Back end DTI 45 % Restructuring Loss Calculation 36 Loan Principal balance before restructuring 450,000 37 Accrued interest, limited to 90 days 8,438 38 Tax and insurance advances 3,000 39 3rd party fees due — 40 Total loan balance due before restructuring 461,438 Assumptions for NPV Calculation, Restructured Loan: 41 Discount rate for projected cash flows 5.530 % 42 Loan prepayment in full 120 Months 43 NPV of projected cash flows 403,000 44 Loss Amount 58,438 Notes to Exhibit 2b (restructuring)
Exhibit 2b. (Alternative Technical Concepts);
Exhibit 2b. The GeneXpert ® System utilizes polymerase chain reaction (PCR) and real-time PCR to amplify and detect target nucleic acid. The system is the first to fully automate and integrate all the steps required for PCR-based testing: sample preparation, amplification and detection. Designed to simplify hands-on preparation, the system provides PCR test results from a raw sample, enabling time-critical tests. The GeneXpert module forms the core of the Biohazard Detection System deployed nationwide by the United States Postal Service for anthrax testing in mail sorting facilities. An expanded menu of tests is currently in development. The GeneXpert System is a random access instrument integrating real-time amplification and detection features seen in the SmartCycler System, but delivering results from unprocessed samples. The I-CORE module is the common technology link between the SmartCycler and GeneXpert, performing real-time amplification and detection. The GeneXpert automates sample preparation, integrating the complex steps of nucleic acid extraction in the microfluidic cartridges. Each GeneXpert module also incorporates a syringe drive, rotary drive and a ultrasonic driver. The driver delivers ultrasonic energy necessary to lyse the raw specimen and release nucleic acids contained within, while the combination of the syringe drive and rotary drive moves liquid between cartridge xxxxxxxx in order to wash, purify and concentrate these nucleic acids. After the automated extraction is complete, the nucleic acid concentrate is moved into the cartridge reaction chamber where amplification and detection takes place. The GeneXpert ® System is the world’s first and only real-time PCR instrument which combines fully integrated sample prep with the amplification and detection process. The cornerstone of the GeneXpert testing process are Cepheid’s patented, self-contained, single use cartridges. This ground-breaking technology allows laboratory and non-laboratory personnel to conduct sophisticated molecular-based testing in a wide range of environments – including hospitals, research laboratories, physician offices, public health clinics or factories. Most DNA analysis and detection procedures start with nucleic acids that have been extracted or removed from the sample. In many cases, samples are complex in composition (whole blood, human cells or tissue, swabs) and the associated sample preparation protocols are complex and time-consuming. In addition, many real world a...
